The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessment of tissue and blood tumor mutational burden in patients with melanoma using a 523-gene clinical assay.
 
Tindaro Giardina
No Relationships to Disclose
 
Timothy Humphries
No Relationships to Disclose
 
Anna Reid
No Relationships to Disclose
 
Nima MesbahArdakani
No Relationships to Disclose
 
Cleo Robinson
No Relationships to Disclose
 
Michael Millward
Consulting or Advisory Role - Amgen; BeiGene; Guardant Health; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Takeda; The Limbic
Research Funding - Abbvie (Inst); Akeso Biopharma (Inst); Albion Laboratories (Inst); Alpine Immune Sciences (Inst); Amgen (Inst); Apollomics (Inst); AstraZeneca (Inst); AtriCure (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); CStone Pharmaceuticals (Inst); Dizal Pharma (Inst); Eucure Biopharma (Inst); Five Prime Therapeutics (Inst); Genentech/Roche (Inst); Genfleet Therapeutics (Inst); GlaxoSmithKline (Inst); InventisBio (Inst); Lilly (Inst); Maxinovel (Inst); Novartis (Inst); Relay Therapeutics (Inst); Roche (Inst); Takeda (Inst); Therapim (Inst); Turning Point Therapeutics (Inst); Vivace Therapeutics (Inst); Vivace Therapeutics (Inst)
 
Elin Gray
Research Funding - Thermo Fisher Scientific
Patents, Royalties, Other Intellectual Property - Patent - Edith Cowan University
 
Benhur Amanuel
No Relationships to Disclose